We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I've fielded has been "When will Multaq® be available?" That happened this week, and the excitement they have shared …
Read More
StopAfib.org and the Atrial Fibrillation Blog are proud to announce our involvement in, and support of, a bill just introduced into the U.S. Senate, S. Res. 220, which would officially designate September as National Atrial Fibrillation Awareness Month. This is the companion bill to H. Res. 255 introduced earlier this year into the U.S. House …
Read More
Medtronic has completed 12 months of follow up in their U.S.-based STOP-AF clinical trial (Sustained Treatment of Paroxysmal Atrial Fibrillation) for treatment of paroxysmal atrial fibrillation. This trial evaluated their cryoballoon catheter, the Arctic Front® CryoAblation Catheter System, which is already approved for use in Europe, Australia and Hong Kong. Learn more: Medtronic Clinical Trial …
Read More
We continue to learn more about the family connection in atrial fibrillation. A second gene was just found that increases the risk of afib and stroke. At least one third of those of European descent carry one copy of the newly-discovered variant in the ZFHX3 gene and have a 20% increase in risk of afib …
Read More
In this video interview, Dr. David Wilber talks about atrial fibrillation catheter ablation clinical trials and afib treatment as reported on at the Heart Rhythm Society 2009 annual meeting. Video Interview with Dr. David Wilber at Heart Rhythm 2009
Read More
In this video interview, Dr. Steven Hao talks about the atrial fibrillation ablation trial, using the THERMOCOOL® catheter, which was presented at the Heart Rhythm Society 2009 annual meeting. He also discussed upcoming catheter ablation studies for afib and improvements in technology to customize atrial fibrillation treatment to a patient's individual anatomy. Video Interview with …
Read More
BREAKING NEWS Multaq(R), the much anticipated replacement for amiodarone, just received FDA approval. Read the press release: FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter
Read More
Through the American Recovery and Reinvestment Act of 2009, the US federal government has allocated $1.1 billion for research into the comparative effectiveness of different medical treatments. New reports just out prioritize atrial fibrillation treatment on this comparative effectiveness research agenda. Comparative effectiveness research has the potential to improve atrial fibrillation patient treatment and save …
Read More